GARDASIL 9 40 ug/.5mL
Human Papillomavirus 9-valent Vaccine, Recombinant · INJECTION, SUSPENSION · Merck Sharp & Dohme LLC
GARDASIL 9 is a injection, suspension containing human papillomavirus 9-valent vaccine, recombinant at 40 ug/.5mL, taken intramuscular. Manufactured by Merck Sharp & Dohme LLC.
Key Facts
- Brand Name
- GARDASIL 9
- Generic Name
- Human Papillomavirus 9-valent Vaccine, Recombinant
- NDC Code (Product)
0006-4121- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 40 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125508
- Marketing Start
- 12/10/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is GARDASIL 9 used for?
GARDASIL 9 contains Human Papillomavirus 9-valent Vaccine, Recombinant. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is GARDASIL 9 a controlled substance?
GARDASIL 9 is not classified as a controlled substance by the DEA.
What is the generic name for GARDASIL 9?
The generic name for GARDASIL 9 is Human Papillomavirus 9-valent Vaccine, Recombinant. There are no other listed brand versions of Human Papillomavirus 9-valent Vaccine, Recombinant.
What is the NDC code for GARDASIL 9 40 ug/.5mL?
The NDC (National Drug Code) for GARDASIL 9 40 ug/.5mL is 0006-4121, listed by Merck Sharp & Dohme LLC.
Other GARDASIL 9 Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)